Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

The FDA’s approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

The vaccine is expected to remain available for anyone who is at least 65 or who has a medical condition, leaving many ...

Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this ...

The FDA's new vaccine guidelines focus on older adults, citing insufficient evidence for the need for additional COVID shots ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy.

WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional ...

A new COVID-19 vaccine has been approved, but it's not available to everyone. Gavin Newsom defies Senate vote: 'Illegal' The longest standing ovation at Cannes? A whopping 22 minutes I’ve been a ...